
On July 10, Bank of America Corp (NYSE:BAC) analyst Allen Lutz published an analyst note on Teladoc Health, Inc (NYSE:TDOC).
What Happened: The Bank of America analyst had a Neutral rating on Teladoc with a $42 price objective. Lutz’s analysis came after the company released two new data points and its second-quarter model assumptions.